ConductScience.org, home

Paper6237904

Mutational resistance to 4-quinolone antibacterial agents.

Smith JT. Eur J Clin Microbiol, 1984. Cited by 85 papers, by iCite.

Cite this record

ConductScience Library. Mutational resistance to 4-quinolone antibacterial agents. Papers, record 6237904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6237904

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutational resistance to 4-quinolone antibacterial agents.
PubMed
Journal
Eur J Clin Microbiol
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
85
iCite
Relative citation ratio, by iCite
4.95
iCite
Revised in PubMed
2019-10-23
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith JTJ T

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Escherichia coliMajor topic
MutationMajor topic
QuinolinesMajor topic
Ciprofloxacin
Dose-Response Relationship, Drug
Drug Resistance, Microbial
Humans
Nalidixic Acid
Norfloxacin
Ofloxacin
Oxazines
Species Specificity

Source PubMed

Download CSV of topics

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1337300Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/337300PubMed
2358918Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/358918PubMed
34895844Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.J Bacteriol1969https://conductscience.org/library/papers/4895844PubMed
47019186The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.J Antimicrob Chemother1981https://conductscience.org/library/papers/7019186PubMed

Download CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.

PMIDTitleJournalYearIn PapersSource
20696087Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients.Epidemiol Infect2011https://conductscience.org/library/papers/20696087PubMed
20643497Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.J Hosp Infect2010https://conductscience.org/library/papers/20643497PubMed
20229318Quantitative structure-activity relationship study of antitubercular fluoroquinolones.Mol Divers2011https://conductscience.org/library/papers/20229318PubMed
19218572Functional relationship between bacterial cell density and the efficacy of antibiotics.J Antimicrob Chemother2009https://conductscience.org/library/papers/19218572PubMed
7689456Quinolone mode of action--new aspects.Drugs1993https://conductscience.org/library/papers/7689456PubMed
3729343In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3729343PubMed
3606077Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3606077PubMed
3532944Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3532944PubMed
3531024Comparative therapeutic activities of ciprofloxacin, amoxicillin, ceftriaxone and co-trimoxazole in a new model of experimental infection with Escherichia coli.Infection1986https://conductscience.org/library/papers/3531024PubMed
3515312Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.Pharm Weekbl Sci1986https://conductscience.org/library/papers/3515312PubMed
3514470[Effect of pH value and magnesium on the antibacterial activity of quinolone preparations].Infection1986https://conductscience.org/library/papers/3514470PubMed
3481314Chemotherapy of otitis media with ofloxacin.Drugs1987https://conductscience.org/library/papers/3481314PubMed
3435123Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3435123PubMed
3292209Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1988https://conductscience.org/library/papers/3292209PubMed
3286517Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver diseases.Infection1988https://conductscience.org/library/papers/3286517PubMed
3159571Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains of Acinetobacter anitratum in vitro.Eur J Clin Microbiol1985https://conductscience.org/library/papers/3159571PubMed
3085584In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3085584PubMed
3065243Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.Infection1988https://conductscience.org/library/papers/3065243PubMed
3019897[Inhibition of gyrase by 4-quinolones: effect on the structure of DNA].Infection1986https://conductscience.org/library/papers/3019897PubMed
3015015Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3015015PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6237904

GET https://conductscience.org/api/papers/v1/6237904/cited_by?page=2